CONMED Corporation (CNMD) Balance Sheet

The improvement in leverage reflects both debt paydown and retained earnings growth, with retained earnings climbing from $489.9M to $645.5M over the same period. This pattern suggests the balance sheet is strengthening organically rather than through asset sales or one-time items. Investors should monitor whether earnings volatility seen in the income statement analysis allows this trajectory to persist.

Debt-to-equity of 0.77 is moderate against peers such as HOLX at 0.52 and MMSI at 0.57, placing CNMD in the middle of the group on leverage. The thin cash position relative to debt means refinancing or repayment depends on continued operating cash generation, which the cash flow analysis shows has been erratic quarter to quarter. This warrants further investigation into maturity schedules, which are not included in the supplied data.

The decline in current ratio over recent quarters suggests a shrinking liquidity cushion, even though the ratio remains above 1.0. Cash balances have hovered between roughly $25M and $48M across the period, which is thin for a company of this size. Liquidity appears adequate for routine operations but offers little buffer should revenue weaken further given the flat top-line trend.

Retained earnings growth of roughly $156M over the period indicates that equity build is primarily earnings-driven rather than from new issuance. Buybacks of $37.0M in 2026Q1 and smaller repurchases thereafter signal a shift in capital return policy following dividend cessation. The quality of this equity growth depends on earnings durability, which the prior income statement analysis flagged as volatile.